CHA submitted a statement for the record for the House Energy and Commerce Oversight and Investigations Subcommittee hearing, “Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains.” Our statement calls on Congress to prioritize the unique health care needs of children when strengthening and stabilizing the nation’s supply chain to forestall shortages. Solutions include requiring manufacturer and distributor transparency, developing proactive shortage mitigation plans, and directing resources to the research and development of pediatric drugs.
CHA Submits Drug Shortages Hearing Statement for the Record
CHA submitted a statement for a House Energy and Commerce hearing to highlight how children’s needs must be prioritized when strengthening the pediatric drug supply chain.
Related Content
How 60 Minutes Can Create System Change
One children’s hospital is helping schools and health care providers move from conflicting messages to coordinated care.
Sep. 02, 2026
How Lullabies Help Babies Thrive
New research is advancing music therapy for extremely premature infants.
Sep. 02, 2026
How CHA Mitigated a Cancer Drug Shortage’s Impact
The recent shortage highlighted pediatrics’ vital need for ifosfamide.
Sep. 01, 2026
